ELI LILLY & Co — Director's Dealing 2011

Jan 28, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2011-01-25

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-25	Restricted Stock Unit	$	A	87924	Acquired	2012-02-01	Common Stock (87924)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.